CompletedPhase 1NCT02018315
Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
Studying Classic glucose transporter type 1 deficiency syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Juan Pascual
- Principal Investigator
- Juan M. Pascual, MD, PhD, ODUniversity of Texas Southwestern Medical Center
- Intervention
- Triheptanoin(drug)
- Enrollment
- 14 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2012 – 2014
Study locations (1)
- UT Southwestern Medical Center, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02018315 on ClinicalTrials.govOther trials for Classic glucose transporter type 1 deficiency syndrome
Additional recruiting or active studies for the same condition.
See all trials for Classic glucose transporter type 1 deficiency syndrome →